Abstract Objectives: To evaluate the results and complications of combined simultaneous arterial re-vascularisation and free flap transfer in patients with critical limb ischaemia and large soft-tissue defects that would otherwise have required major amputation. Design: Retrospective analysis of all combined procedures performed between 1993 and 2007 with regard to complications and outcome. Materials and methods: Seventy-eight procedures were performed in 76 patients with a mean age of 60 years (range: 18e80 years). The majority had diabetes (70.5%). Follow-up was obtained from hospital charts and telephone contacts with patients or GPs. Results: The limb-salvage rate was 93% after 1 year, 80% after 3 years and 71% after 5 years. Perioperative complications occurred in 50% of the patients; six out of 78 (7.7%) arterial reconstructions and 13 out of 78 (16.7%) flaps had to be revised during the early postoperative period. However, most flaps could be saved by a secondary procedure resulting in an early failure (amputation) rate of 6%.
Introduction
The increasing prevalence of diabetes and continuing tobacco consumption still lead to a rise in the number of patients with critical limb ischaemia and large soft-tissue defects. Despite the increasing possibilities of distal (endovascular) re-vascularisation and new wound-healing techniques, wound healing and limb salvage can often not be obtained when bones and/or tendons are exposed (TASC II). 1 Major amputation, although sometimes unavoidable, seldom leads to independent ambulation, is more expensive than a successful re-vascularisation and negatively influences life expectancy. 2 Combined lower limb re-vascularisation and free-tissue transfer to cover a large and deep defect immediately provides adequate blood supply and coverage of the wound with living tissue, leading to expedient healing and full-length limb salvage.
Despite this technique being first described more than 20 years ago, it has not obtained widespread acceptance, probably due to the presumed technical difficulties of the procedure and the fear for morbidities or complications.
Therefore, we retrospectively evaluated our 15 years of experience with special interest for the results with regard to limb salvage, ambulation and the risks and complications of the procedure.
Material and Methods

Patient selection
All the records of simultaneous combined re-vascularisation and free-tissue transfer procedures (76 consecutive patients with a total of 78 combined procedures) performed between 1993 and 2007 were reviewed. This combined procedure was the last attempt to avoid a major below-or above-knee amputation, consequently patients excluded for co-morbidities or unreconstructable ischaemia were generally amputated. All patients had a large soft-tissue deficit (exposed bone and/or tendon) (Rutherford grade 6) and most were referred to our centre as lost case for limb salvage. Only patients capable of regaining functional ambulatory status were considered for operation. The follow-up lasted till April 2007, till major amputation or death.
Procedure
All patients had a preoperative angiography to determine the extent of the arterial disease and to choose the appropriate inflow and outflow vessel for the bypass graft.
Whenever possible, we preferred a simultaneous intervention to a staged procedure. Advantages of a simultaneous re-vascularisation and tissue transfer are that it is easier to connect the free flap to the arterial bypass and dissect the concomitant veins when no scar tissue is formed yet, it shortens the operation time (the flap was prepared by the plastic surgeons while vascular surgeons performed the bypass graft) and the outflow of the arterial re-vascularisation is enhanced by the free muscle flap transfer. When not too extensive, we even prefer to combine the debridement with the actual procedure to avoid further dissection of the debrided tissue.
The ipsilateral greater saphenous vein was preferred for distal re-vascularisations in an in-situ or in a non-reversed non-in-situ fashion; if unavailable, a reversed contralateral saphenous vein was used. When no ipsi-or contralateral saphenous vein was available, a cryopreserved homologous saphenous vein was favoured because of its length and resistance to infection (most patients had osteomyelitis at the defect). Heparin (100 IU kg À1 ) was administered 2 min before anastomosis of the bypass graft. In 64% of the patients, a minor debridement or amputation was needed for osteomyelitis or gangrene before flap insertion.
Typically, a side-to-side anastomosis was performed on the distal pedal vessel leaving one end of the saphenous vein for an end-to-end anastomosis with the flap artery. In other cases, the re-vascularised tibial artery closest to the defect was used as inflow source for the free flap. The nearest concomitant tibial vein served as an outflow for the flap through an end-to-end anastomosis. If no deep vein was accessible, we anastomosed to a neighbouring superficial vein (six patients) or a mobilised lesser saphenous vein (six patients). At first we preferred the rectus abdominis muscle flap as a donor but due to donor-site wound-healing complications, gastroparesis and the fact that the inferior epigastric artery was frequently affected by atherosclerosis, we now favour the anterolateral thigh flap (ALT). According to our excellent results in reconstructive breast surgery, we recently switched to the use of perforator flaps, leaving the muscle in place and just transferring fat and skin tissue with its pedicle; This results in less postoperative pain and fewer wound-healing problems. The muscular flaps were fixed and covered with split-thickness skin grafts (Figs. 1e3) .
Postoperative meticulous monitoring of the arterial graft and free muscle flap was achieved by hourly Doppler examination and temperature control. All patients were treated on an air-fluidised bed to prevent decubitus ulcers or pressure on the flap. As soon as the wound healed, a slightly compressive elastic stocking was applied for about 6 months to remodel the transferred muscle. Ambulation started in the third postoperative week. The median hospital stay was 48.3 days (range: 14e113 days). Some hospital stays were extended for social back-up problems. Patients were followed with serial duplex scanning of the arterial reconstruction and inspection of the free flap.
At present standard postoperative medication consists of daily low-dose aspirin and 72 h intravenous heparin followed by low-molecular-weight heparin (LMWH) in a prophylactic dose till ambulation, combined with clopidogrel or coumarins according to their co-morbidity. The patients were followed with serial duplex scanning of the arterial and flap reconstruction at 1 month, 3, 6, 12 months and then annually. Long-term follow-up was assessed through postoperative visits or telephone calls to treating physicians. Successful ambulatory function was defined as the ability of the patient to walk alone or with a cane or walker. Patients requiring a wheelchair for mobility or using their leg only for pivot functions were considered as non-ambulatory. 
Data collection and statistics
Amputation free survival and patient survival were defined as primary end-points. All pre-and postoperative data were obtained from patient files at our department and from the referring physicians. This retrospective study with prospective follow-up complied with the Declaration of Helsinki and was approved by the ethics committee of the Ghent University Hospital. Limb salvage and combined limb salvage patient survival analyses were obtained through the KaplaneMeier survival analysis.
Co-variate interactions with treatment (diabetes, clinical stratification group, renal failure and others) were examined with a chi-square (c 2 ) test and ManneWhitney U-test; odds ratios were calculated with the 95% confidence levels. Probability values were compared with the p > 0.05 level used to determine statistical significance.
Results
Seventy-eight limbs in 76 patients were treated with this combined simultaneous procedure over a 15-year period (January 1992 to April 2007) for critical limb ischaemia (CLI) Rutherford 6 (84%), major vascular trauma (13%) or large tissue loss from gangrene resulting from multiple organ failure with pre-existing arterial disease (3%).
The majority of the patients were men: 62 men for 16 women, median age was 65.5 years (range: 18e80 years). The most frequent location for free flap transfer was the forefoot after open or non-healing forefoot amputation (Table 1) .
Risk factors are shown in Table 2 : 55 patients (70%) had diabetes, 29 patients suffered from chronic renal insufficiency of whom three patients were on dialysis and three previously had a kidney transplantation. Four patients had a contralateral major amputation. 38% a documented osteomyelitis on radiography and magnetic resonance imaging (MRI) and one-third of the patients had undergone a distal arterial reconstruction in the past.
The majority of the vascular procedures were popliteopedal bypasses (Table 3) , eight patients needed an arterial reconstructions at two different levels.
A variety of muscular and non-muscular free flaps were used to cover the defect (Table 4) .
Early results
The overall median operating time for a single-stage procedure including anaesthesia time was 415 min (7 h) (range: 150e730 min). Twenty-three patients (29%) required an early re-intervention: six vascular bypasses thrombosed, 13 free muscle flaps failed, two patients needed a re-exploration for bleeding and one patient developed a false aneurysm on the bypass which was excised. One patient developed a forefoot necrosis after connecting the flap to the posterior tibial artery (the only outflow artery with a non-existing pedal arch) for heel coverage due to a steal phenomenon from the flap and had to be amputated. Four failing vascular bypasses were treated by thrombectomy, combined with local thrombolysis of the free flap; in the other two patients, a more distal bypass was performed. Four failed free flaps required a major amputation whereas the remaining patients were re-explored. In five patients, the thrombi could be cleared and a new arterial and venous anastomosis of the flap was performed. Two patients were treated with a new free flap transfer and two patients had granulation stimulation with a vacuum device followed by a rotation flap and a skin graft (STG). In five patients, a new STG had to be performed. The overall early complication rate was 50% (Table 5) .
Major medical complications occurred in six patients: three developed congestive heart failure with fatal consequence resulting in an in-hospital mortality rate of 3.8% and three patients suffered a stroke that resolved without persisting disability. Minor surgical complications were numerous and included superficial wound dehiscence, 
Late results
Long-term follow-up was available in 70 limbs (three patients died and five were amputated in the perioperative period) for an average of 32.5 m (range: 1e180 m). During follow-up, another 17 patients (21%) needed a major amputation owing to progression of gangrene, vascular graft occlusion or progression of atherosclerosis in the outflow vessels. Twelve of these 17 patients (71%) had renal insufficiency and the limbs of two of the three patients on dialysis were amputated during follow-up. Five patients required a new bypass; in five other patients the bypass occluded without consequences for the free muscle flap. Five angioplasties were performed for in-graft stenoses. Fourteen patients died during follow-up. The limb salvage ratio at 1, 3 and 5 years was 93%, 80% and 71%, respectively, and the combined patient survival and limb-salvage rate was 85%, 66% and 51% at 1, 3 and 5 years, respectively (Fig. 4) .
Sixty-five percent of the patients were still alive and able to ambulate independently with the use of their reconstructed limb 1 year after hospital discharge.
In the evaluation of possible predictive risk factors for poor outcome, only previous foot operations/minor amputations were a statistically significant negative predictive risk factor (p < 0.024, odds ratio: 9.049 (range: 1.336e 61.294)) for patient survival. For limb salvage, only renal insufficiency (p < 0.002; odds ratio: 16.3 (range: 2.8e95.9)) and previous contralateral major amputation (p < 0.03; odds ratio: 89.5 (range: 4.7e1701.7)) were very strong predictors for limb loss. Diabetes alone, or in combination with other risk factors, was not a statistically significant risk factor for patient survival or limb loss. The type of flap, the type of arterial re-vascularisation and the outflow state (nearly all had only one outflow vessel) had no effect on limb salvage.
Discussion
Combined re-vascularisation and free muscle flap transfer was first described more than 20 years ago by Briggs 3 et al. The technique has been adapted all over the world but 5 refined and validated this approach for patients with large soft-tissue defects, especially on weight-bearing surfaces of the foot and drew attention to the increased outflow for the bypass brought by the muscle flap. Mimoun et al. 6 first made the observation that neovascularisation of the surrounding ischemic tissue by collaterals originating from the flap occurs as soon as 3 weeks after implantation and called this flap the 'nictrient flap'. We confirmed this observation in a later report. 7 At a further stage, these collaterals can allow the flap to survive, even when the bypass occludes. Shestak 8 confirmed the fact that a free flap can serve as a sole outflow for a bypass graft in patients with unacceptable or no runoff.
The work of Lorenzetti 9 showed that the transferred muscle provides a low-resistance outflow bed, increasing graft flow by up to 50% and that a steal phenomenon was not to be feared even if a substantial part of the flow through the bypass went to the muscle. Yet, we had one patient who needed a major amputation despite an open bypass due to a steal phenomenon of the flap on the heel and progressive gangrene of the forefoot.
The misconception that patients with distal arterial occlusions and major tissue loss (Rutherford 5e6), especially diabetes patients, are not suitable for reconstruction has long been a motive for primary amputation : Chung 10 observed that at 1-year follow-up up to 25% of his patients with CLI did not realise wound healing despite a successful re-vascularisation, 19% lost ambulatory function and 5% had lost independent living status. Risk factors for amputation despite a patent bypass graft were persistent ischaemia or infection of the foot wound, poor wound healing, distal outflow problems and the lack of durable wound coverage. Adequate tissue coverage of the distal anastomotic site in patients with large soft-tissue deficit is difficult and can result in graft exposure and disruption of the graft or the anastomosis. By covering the distal anastomosis site with a free muscle flap, we can prevent disruption of the arterial bypass and cover at the same time major soft-tissue lesions. Our combined survival and limb-salvage rate was 85% after 1 year. As limb salvage has a clear impact on quality of life and probably survival, we think that primary amputation is only indicated in patients who are bedridden, who have severe neurological impairment, and who have a poor survival or poor predicted functional outcome after re-vascularisation and free flap transfer.
The known risk factors for failures in patients with tissue loss who undergo infra-inguinal vein bypass surgery are diabetes, end-stage renal disease and poor run off. 11 In our study, only renal insufficiency and previous major amputation of the other limb were strong predictors for limb loss. Therefore, this operation in patients with end-stage renal disease or on dialysis was discontinued. The fact that diabetes was no risk factor may be due to the fact that the muscle flap increased the outflow. Tukiainen 12e14 mentioned other predictive factors that enhance poor graft outcome, such as male gender and the size of the ulcer (>10 cm 2 ). All our patients had an ulcer larger than 10 cm 2 . Another misconception about this combined procedure is the high mortality rate. We agree that we had a lot of minor complications (50%) and a high number of early reinterventions, although these resulted in only five major amputations. However, our in-hospital mortality rate of 3.8% compares favourably to the mortality rates after major amputation that can be as high as 50%.
Even our 1-year mortality and amputation rate of 15% and 7% are consistent with the 1-year mortality (10%) and amputation rate (5e10%) in patients with CLI and just minor tissue deficit. Postoperative mortality was only attributable to cardiac causes. This stresses the importance of a thorough cardiac evaluation and adequate management before, during and after the intervention. Our low mortality rate could only be achieved due to a meticulous cardiac workup. Under these conditions, the expanded operation and extended operation time do not seem to adversely affect the perioperative mortality rate. Despite the advanced stage of vascular disease in all our patients, our 5-year limb-salvage rate of 71% is comparable to the limb-salvage rate obtained after arterial re-vascularisation for critical limb ischaemia alone.
1 Only a few centres published the results about combined re-vascularisation and free-tissue transfer (with exclusion of omental flaps) in more than 10 patients (Table 6 ). In these series and related to the disease itself, late mortality is often high and follow-up limited. Nevertheless, a 3-year limb-salvage rate about 70% could be obtained in most series. We obtained a similar limb-salvage rate even after 5 years.
During the last years, growing interest has arisen for new wound-healing techniques, such as vacuum-assisted closure or negative pressure treatment. This has been proposed as an alternative for this technique as it would enhance wound healing and allow the formation of granulating tissue over bones and tendons. However, in patients with arterial compromise, this technique will only work after a re-vascularisation has been performed. Time to healing with these conservative techniques is much longer, and it cannot be used on weight-bearing surfaces and cannot be combined with a pedal bypass to the affected region. Although this is a valuable technique, it is an alternative for the combined technique in only a limited number of patients.
Conclusion
Our results show that arterial re-vascularisation in combination with free-tissue transfer can be performed safely with acceptable morbidity and mortality. In patients with large soft-tissue defects that cannot be expected to heal in a reasonable time it should be preferred over a major amputation. Only end-stage renal disease should be considered as a contraindication. The combination of both procedures in one intervention has several advantages: a supplementary outflow is created for the vascular reconstruction, the arterial and venous anastomoses with the free flap are easier to perform and an immediate coverage of the defect is obtained. The vast majority of our patients were able to regain ambulatory function.
Our 5-year results can be considered as excellent and illustrate the improvement of limb salvage and, therefore, of quality of life, that can be obtained in these patients.
